• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BECTON DICKINSON INFUSION THERAPY SYSTEMS INC. NEXIVA DUAL PORT WITH Q-SYTE, 20G X 1.0; INTRAVASCULAR CATHETER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BECTON DICKINSON INFUSION THERAPY SYSTEMS INC. NEXIVA DUAL PORT WITH Q-SYTE, 20G X 1.0; INTRAVASCULAR CATHETER Back to Search Results
Model Number 383536
Device Problem Leak/Splash (1354)
Patient Problem Rupture (2208)
Event Date 03/16/2022
Event Type  malfunction  
Event Description
It was reported while using nexiva dual port with q-syte, 20g x 1.0 leakage occurred.The following information was provided by the initial reporter: in the middle of the examination, the procedure must be stopped due to contrast explosion, since the psi of the syringe exceeded that of the device.
 
Manufacturer Narrative
Date of event is unknown; awareness date has been used for this field.A device evaluation is anticipated but has not yet begun.Upon completion of the investigation, a supplemental report will be filed.
 
Manufacturer Narrative
H6: investigation summary: our quality engineer inspected the photographs submitted for evaluation.Bd received two photographs which displayed a representative unit in the sealed package.The photographs provided for this incident did not present sufficient evidence to identify or confirm the alleged failure or to establish a definite root cause.Per the ifu (instructions for use), it may be caused by exceeding the maximum power injector pressure of 300psi during the power injection.A device history record review showed no non-conformances associated with this issue during the production of this batch.
 
Event Description
It was reported while using nexiva dual port with q-syte, 20g x 1.0 leakage occurred.The following information was provided by the initial reporter: in the middle of the examination, the procedure must be stopped due to contrast explosion, since the psi of the syringe exceeded that of the device.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
NEXIVA DUAL PORT WITH Q-SYTE, 20G X 1.0
Type of Device
INTRAVASCULAR CATHETER
Manufacturer (Section D)
BECTON DICKINSON INFUSION THERAPY SYSTEMS INC.
9450 south state street
sandy UT 84070
Manufacturer (Section G)
BECTON DICKINSON INFUSION THERAPY SYSTEMS INC.
9450 south state street
sandy UT 84070
Manufacturer Contact
phillip emmert
9450 south state street
sandy, UT 84070
8015296192
MDR Report Key14015507
MDR Text Key288613923
Report Number1710034-2022-00171
Device Sequence Number1
Product Code FOZ
UDI-Device Identifier30382903835363
UDI-Public30382903835363
Combination Product (y/n)N
Reporter Country CodeCI
PMA/PMN Number
K102520
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Foreign,User Facility
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date 06/02/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date02/29/2024
Device Model Number383536
Device Catalogue Number383536
Device Lot Number1068454
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 03/16/2022
Initial Date FDA Received04/05/2022
Supplement Dates Manufacturer Received06/02/2022
Supplement Dates FDA Received07/01/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured03/10/2021
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
-
-